Novo Nordisk A/S (ETR:NOV)

Novo Nordisk Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	243,918	371,731	417,564	284,852	225,277	132,551
Market Cap Growth	-10.98%	-10.98%	46.59%	26.45%	69.96%	8.92%
Enterprise Value	254,165	369,330	414,739	283,305	222,367	129,679
Last Close Price	54.96	82.37	91.27	61.01	46.72	26.90
PE Ratio	18.01	27.45	37.19	38.16	35.07	23.41
PS Ratio	6.26	9.55	13.40	11.97	11.90	7.77
PB Ratio	12.68	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	56.15	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	24.65	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	15.04	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	6.53	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	12.80	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	13.56	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	25.68	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.72	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.69	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.39	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.74	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.20	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.52	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.74	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	80.77%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	22.41%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Capital (ROIC)	46.03%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	56.30%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	5.55%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	4.06%	2.66%	2.67%	3.15%	2.90%	4.67%
Dividend Yield	2.85%	1.86%	1.38%	1.37%	1.50%	2.27%
Payout Ratio	43.71%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.71%	0.71%	1.10%	1.34%	1.58%	1.63%
Total Shareholder Return	3.56%	2.56%	2.48%	2.70%	3.07%	3.90%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.